Adastra Holdings (XCNQ:XTRX) Days Sales Outstanding : 75.60 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Adastra Holdings Days Sales Outstanding?

Adastra Holdings's average Accounts Receivable for the three months ended in Dec. 2023 was C$4.14 Mil. Adastra Holdings's Revenue for the three months ended in Dec. 2023 was C$5.00 Mil. Hence, Adastra Holdings's Days Sales Outstanding for the three months ended in Dec. 2023 was 75.60.

The historical rank and industry rank for Adastra Holdings's Days Sales Outstanding or its related term are showing as below:

XCNQ:XTRX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 61.36 Med: 73.46 Max: 141.82
Current: 65.23

During the past 5 years, Adastra Holdings's highest Days Sales Outstanding was 141.82. The lowest was 61.36. And the median was 73.46.

XCNQ:XTRX's Days Sales Outstanding is ranked better than
56.41% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs XCNQ:XTRX: 65.23

Adastra Holdings's Days Sales Outstanding declined from Dec. 2022 (84.65) to Dec. 2023 (75.60).

Adastra Holdings Days Sales Outstanding Historical Data

The historical data trend for Adastra Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adastra Holdings Days Sales Outstanding Chart

Adastra Holdings Annual Data

Trend

Apr19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

141.82

78.23

68.69

61.36

Adastra Holdings Quarterly Data
	Oct18	Oct19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial													84.65	62.10	51.47	84.87	75.60

Competitive Comparison of Adastra Holdings's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Adastra Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adastra Holdings's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adastra Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Adastra Holdings's Days Sales Outstanding falls into.

Adastra Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Adastra Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (3.562	+	3.91)	/	2 )	/	22.223	*	365
=	3.736					/	22.223	*	365
=	61.36

Adastra Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (4.375	+	3.91)	/	2 )	/	5	*	365 / 4
=	4.1425					/	5	*	365 / 4
=	75.60

Adastra Holdings (XCNQ:XTRX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Adastra Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Adastra Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Adastra Holdings (XCNQ:XTRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adastra Holdings Ltd (XCNQ:XTRX) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

XTXXF:USA D2E:Germany

Address

275th Street, Suite 5451, Langley, BC, CAN, V4W 3X8

Website

https://www.adastraholdings.ca

Adastra Holdings Ltd is an extraction and processing solutions company. It aims to develop and deploy large-scale cannabis and hemp extraction technologies and provide turnkey processing solutions to help licensed standard and micro-cultivators maximize the value of every harvest. The company has two operating segments comprised of manufacturing and non-manufacturing operations. The manufacturing operations include the manufacturing, sale, and distribution of cannabis-related products, and the non-manufacturing operations include PerceiveMD.

Executives

Lachlan Clyde Mcleod

Senior Officer

Adastra Holdings (XCNQ:XTRX) Headlines

No Headlines